Document Detail


Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm.
MedLine Citation:
PMID:  15574176     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Electrical storm (ES) is characterized by either refractory ventricular tachycardia (VT) or ventricular fibrillation (VF). However, little is known about the prevalence, predictors, and mortality implications of the causative arrhythmia in ES. We sought to assess the prevalence, predictors, and survival significance of VT and VF as the causative arrhythmia of ES in implantable cardioverter defibrillator (ICD) patients. METHODS AND RESULTS: Consecutive patients from January 2000 to December 2002 who presented to the ICD clinic with > or = 2 separate ventricular arrhythmic episodes requiring shock within 24 hours were included in the study. ICD interrogation confirmed the number of shocks and provided electrograms for interpretation of the causative arrhythmia. Patients were grouped as VF or VT according to the causative arrhythmia. Their prevalence, predictors, and mortality rates were compared. Of 2,028 patients assessed in the ICD clinic, 208 (10%) presented with ES. VF was the cause of ES in 99 of 208 patients, for an overall prevalence of 48%. Original ICD indication, coronary artery disease, and amiodarone therapy were predictive for the causative arrhythmia. There was no mortality difference between the VT and VF groups; however, both groups had significantly increased mortality compared to a control ICD population without ES. CONCLUSION: VF is the causative arrhythmia for a sizable proportion of patients with ES. The initial ICD indication, coronary artery disease, and amiodarone therapy are predictors of the causative arrhythmias in ES. There does not appear to be any mortality difference between ES patients with VT and VF, but mortality is increased in patients with ES versus control ICD patients without ES.
Authors:
Atul Verma; Fethi Kilicaslan; Nassir F Marrouche; Stephen Minor; Mohammed Khan; Oussama Wazni; J David Burkhardt; William A Belden; Jennifer E Cummings; Ahmad Abdul-Karim; Walid Saliba; Robert A Schweikert; Patrick J Tchou; David O Martin; Andrea Natale
Related Documents :
15840466 - Defibrillation threshold testing: is it really necessary at the time of implantable car...
3599366 - Endomyocardial biopsy approach to patients with ventricular tachycardia with special re...
1131556 - Behaviour of the dying patient.
7724386 - Results of delivered therapy for vt or vf in patients with third-generation implantable...
18657666 - Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with...
128336 - Evaluation of endarterectomy for aortoiliac and aortoiliofemoral occlusive disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  15     ISSN:  1045-3873     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-12-02     Completed Date:  2005-04-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1265-70     Citation Subset:  IM    
Affiliation:
Cleveland Clinic Foundation, Section of Pacing and Electrophysiology, Cleveland, Ohio 44195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Arrhythmias, Cardiac / complications*,  mortality
Defibrillators, Implantable* / adverse effects
Female
Humans
Male
Prevalence
Prognosis
Recurrence
Survival Analysis
Tachycardia, Ventricular / etiology*,  mortality
Ventricular Fibrillation / etiology*,  mortality

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads.
Next Document:  Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts.